Our products

Our products pipeline is diverse, from therapeutics to diagnostics, and changes over time as new molecules and devices progress from discovery to development and ultimately approval where they become available to patients.

read more
Sort
  • indication
  • project
  • partnership
  • stage

indication

Schizophrenia

project

AB-1005-01/MRTU

partnership

Government fund

stage

Preclinical

indication

Pain

project

AB-1110-21/WREA

partnership

Investors fund

stage

Preclinical

indication

Oncology

project

AB-3020-01/MRHB

partnership

Academic fund

stage

Preclinical

indication

Infection

project

AB-4030-21/YBYS

partnership

Investors fund

stage

Phase 2

indication

Diagnostic

project

AB-3025-11/MRHB

partnership

Academic fund

stage

Preclinical

indication

GI

project

AB-2115-21/NRMR

partnership

Investors fund

stage

Phase 1

Interested in finding out more? Get in touch today

We aim to get back to you within 24 hours.